Deutsche Bank’s Syneron Medical Ltd ELOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-46,781
Closed -$512K 5317
2017
Q2
$512K Sell
46,781
-385,011
-89% -$4.22M ﹤0.01% 3436
2017
Q1
$4.55M Buy
431,792
+10,300
+2% +$99.6K ﹤0.01% 1735
2016
Q4
$3.54M Buy
421,492
+38,969
+10% +$305K ﹤0.01% 1887
2016
Q3
$2.74M Sell
382,523
-71,450
-16% -$497K ﹤0.01% 2140
2016
Q2
$3.49M Sell
453,973
-63,198
-12% -$451K ﹤0.01% 2019
2016
Q1
$3.78M Sell
517,171
-16,700
-3% -$120K ﹤0.01% 1943
2015
Q4
$4.12M Buy
533,871
+24,847
+5% +$189K ﹤0.01% 1926
2015
Q3
$3.64M Sell
509,024
-5,686
-1% -$54.6K ﹤0.01% 2028
2015
Q2
$5.47M Buy
514,710
+9,910
+2% +$116K ﹤0.01% 1739
2015
Q1
$6.25M Buy
504,800
+106,507
+27% +$1.18M ﹤0.01% 1646
2014
Q4
$3.71M Buy
398,293
+5,164
+1% +$49.8K ﹤0.01% 2196
2014
Q3
$3.94M Sell
393,129
-6,926
-2% -$70.5K ﹤0.01% 2007
2014
Q2
$4.13M Sell
400,055
-48,430
-11% -$524K ﹤0.01% 1954
2014
Q1
$5.58M Sell
448,485
-33,977
-7% -$402K ﹤0.01% 1737
2013
Q4
$5.93M Sell
482,462
-4,100
-0.8% -$42.6K ﹤0.01% 1655
2013
Q3
$4.19M Buy
486,562
+98,664
+25% +$852K ﹤0.01% 1951
2013
Q2
$3.37M Buy
+387,898
New +$3.47M ﹤0.01% 1866

Other funds holding ELOS

Deutsche Bank's ELOS Position: Q3 2017 in Review

Deutsche Bank sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 46,781 shares — an estimated $512K sold.

Deutsche Bank first reported a position in ELOS in Q2 2013 and held it in 17 quarters. The position peaked at $6.25M in Q1 2015. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Deutsche Bank reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Deutsche Bank sold 46,781 Syneron Medical Ltd shares in Q3 2017, an estimated $512K.
  • Deutsche Bank first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 17 quarters.
  • Deutsche Bank's Syneron Medical Ltd position peaked at $6.25M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Deutsche Bank's 13F filing for Q3 2017, filed 14 Nov 2017.